Home
Cormorant Asset Management reported a 5.97% stake in enGene Therapeutics ENGN · 4,000,000 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 5.97%
- Last report
- First report
- Shares held
- 4,000,000 sh
- Class
- Common Shares
- Event date
- 25/12/31
- Filed
- 26/02/17
First 5%+ report · 5.97% stake
enGene Therapeutics trades, last 26 weeks
What else happened in enGene Therapeutics around then
Filed or reported within 30 days of the trade day · 25/12/01~01/30Cormorant Asset Management's other 5% stake reports
- Cormorant Asset Management
5% stakeRallybio
5% stakeRallybio
RLYB
0% stake
0 sh
0% stake
Filed 08/14
- Cormorant Asset Management
5% stakeQuince Therapeutics
5% stakeQuince Therapeutics
QNCX
9.99% stake
108,029 sh
9.99% stake
Filed 08/14
- Cormorant Asset Management
5% stakeMoonLake Immunotherapeutics
5% stakeMoonLake Immunotherapeutics
MLTX
4.35% stake
3,205,433 sh
4.35% stake
Filed 08/14
- Cormorant Asset Management
5% stakeEyePoint
5% stakeEyePoint
EYPT
8.35% stake
7,000,000 sh
8.35% stake
Filed 08/14
- Cormorant Asset Management
5% stakeCabaletta Bio
5% stakeCabaletta Bio
CABA
5.95% stake
10,000,000 sh
5.95% stake
Filed 08/14
